Rezolute, Inc. FY 2026: Revenue $0 Net loss $77.6M, EPS $(0.75) — 10-K Summary
Rezolute, Inc. reported fiscal 2026 results as a clinical-stage company with no product revenue: Revenue was $0 and the company posted a net loss of $77.6M, or $(0.75) diluted EPS, compared with a net loss of $74.4M and $(0.98) diluted EPS in fiscal 2025.Financial HighlightsBusiness HighlightsOrigi…